nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxorubicin—ABCB11—bile—celiac disease	0.0542	0.0687	CbGeAlD
Doxorubicin—ABCC2—bile—celiac disease	0.0276	0.035	CbGeAlD
Doxorubicin—SLC22A16—blood—celiac disease	0.0158	0.02	CbGeAlD
Doxorubicin—RALBP1—Rho GTPase cycle—ARHGAP31—celiac disease	0.0136	0.0645	CbGpPWpGaD
Doxorubicin—ABCB8—blood—celiac disease	0.0123	0.0156	CbGeAlD
Doxorubicin—AKR1A1—smooth muscle tissue—celiac disease	0.0121	0.0154	CbGeAlD
Doxorubicin—NDUFS7—connective tissue—celiac disease	0.0121	0.0153	CbGeAlD
Doxorubicin—NOS2—IL23-mediated signaling events—IL23R—celiac disease	0.0119	0.0565	CbGpPWpGaD
Doxorubicin—CBR3—blood—celiac disease	0.0118	0.015	CbGeAlD
Doxorubicin—NOS2—IL23-mediated signaling events—IL18RAP—celiac disease	0.0114	0.0539	CbGpPWpGaD
Doxorubicin—AKR1A1—pancreas—celiac disease	0.0112	0.0142	CbGeAlD
Doxorubicin—NOS2—Alpha9 beta1 integrin signaling events—TGM2—celiac disease	0.0111	0.0525	CbGpPWpGaD
Doxorubicin—NQO1—gall bladder—celiac disease	0.0107	0.0135	CbGeAlD
Doxorubicin—NDUFS2—connective tissue—celiac disease	0.01	0.0127	CbGeAlD
Doxorubicin—NDUFS3—connective tissue—celiac disease	0.00988	0.0125	CbGeAlD
Doxorubicin—AKR1A1—lymphoid tissue—celiac disease	0.00971	0.0123	CbGeAlD
Doxorubicin—ABCB8—liver—celiac disease	0.00961	0.0122	CbGeAlD
Doxorubicin—AKR1A1—digestive system—celiac disease	0.00959	0.0122	CbGeAlD
Doxorubicin—ABCC3—gall bladder—celiac disease	0.00958	0.0121	CbGeAlD
Doxorubicin—NOS1—epithelium—celiac disease	0.00955	0.0121	CbGeAlD
Doxorubicin—NOS1—smooth muscle tissue—celiac disease	0.0092	0.0117	CbGeAlD
Doxorubicin—NDUFS2—smooth muscle tissue—celiac disease	0.00915	0.0116	CbGeAlD
Doxorubicin—ABCC6—connective tissue—celiac disease	0.00914	0.0116	CbGeAlD
Doxorubicin—AKR1A1—blood—celiac disease	0.00913	0.0116	CbGeAlD
Doxorubicin—NDUFS3—smooth muscle tissue—celiac disease	0.00903	0.0115	CbGeAlD
Doxorubicin—NDUFS7—digestive system—celiac disease	0.00871	0.011	CbGeAlD
Doxorubicin—YWHAG—connective tissue—celiac disease	0.00861	0.0109	CbGeAlD
Doxorubicin—NDUFS2—pancreas—celiac disease	0.00846	0.0107	CbGeAlD
Doxorubicin—NDUFS3—pancreas—celiac disease	0.00835	0.0106	CbGeAlD
Doxorubicin—NDUFS7—blood—celiac disease	0.0083	0.0105	CbGeAlD
Doxorubicin—RALBP1—Rho GTPase cycle—MYO9B—celiac disease	0.00825	0.0391	CbGpPWpGaD
Doxorubicin—AURKA—lymphoid tissue—celiac disease	0.0082	0.0104	CbGeAlD
Doxorubicin—AURKA—digestive system—celiac disease	0.0081	0.0103	CbGeAlD
Doxorubicin—DHCR7—pancreas—celiac disease	0.00794	0.0101	CbGeAlD
Doxorubicin—YWHAG—smooth muscle tissue—celiac disease	0.00788	0.00999	CbGeAlD
Doxorubicin—SLC22A16—SLC-mediated transmembrane transport—SLC9A4—celiac disease	0.00779	0.0369	CbGpPWpGaD
Doxorubicin—NOS2—IL12-mediated signaling events—IL18RAP—celiac disease	0.00773	0.0366	CbGpPWpGaD
Doxorubicin—AURKA—blood—celiac disease	0.00772	0.00979	CbGeAlD
Doxorubicin—NOS3—connective tissue—celiac disease	0.00765	0.0097	CbGeAlD
Doxorubicin—CYP3A4—urine—celiac disease	0.00763	0.00967	CbGeAlD
Doxorubicin—CYP2D6—urine—celiac disease	0.0075	0.00951	CbGeAlD
Doxorubicin—NDUFS2—lymphoid tissue—celiac disease	0.00731	0.00927	CbGeAlD
Doxorubicin—YWHAG—pancreas—celiac disease	0.00728	0.00923	CbGeAlD
Doxorubicin—NOS1—digestive system—celiac disease	0.00727	0.00921	CbGeAlD
Doxorubicin—NOS3—epithelium—celiac disease	0.00726	0.00921	CbGeAlD
Doxorubicin—NDUFS2—digestive system—celiac disease	0.00722	0.00916	CbGeAlD
Doxorubicin—NDUFS3—lymphoid tissue—celiac disease	0.00722	0.00915	CbGeAlD
Doxorubicin—RALBP1—Rho GTPase cycle—TAGAP—celiac disease	0.00716	0.0339	CbGpPWpGaD
Doxorubicin—AKR1A1—liver—celiac disease	0.00714	0.00906	CbGeAlD
Doxorubicin—NDUFS3—digestive system—celiac disease	0.00713	0.00904	CbGeAlD
Doxorubicin—RALBP1—smooth muscle tissue—celiac disease	0.00711	0.00902	CbGeAlD
Doxorubicin—NOS3—smooth muscle tissue—celiac disease	0.007	0.00887	CbGeAlD
Doxorubicin—NOS1—blood—celiac disease	0.00692	0.00878	CbGeAlD
Doxorubicin—NDUFS2—blood—celiac disease	0.00688	0.00872	CbGeAlD
Doxorubicin—DHCR7—lymphoid tissue—celiac disease	0.00686	0.0087	CbGeAlD
Doxorubicin—NDUFS3—blood—celiac disease	0.0068	0.00862	CbGeAlD
Doxorubicin—DHCR7—digestive system—celiac disease	0.00678	0.00859	CbGeAlD
Doxorubicin—RALBP1—pancreas—celiac disease	0.00658	0.00834	CbGeAlD
Doxorubicin—AKR1C3—smooth muscle tissue—celiac disease	0.00656	0.00831	CbGeAlD
Doxorubicin—NDUFS7—liver—celiac disease	0.00649	0.00823	CbGeAlD
Doxorubicin—DHCR7—blood—celiac disease	0.00646	0.00819	CbGeAlD
Doxorubicin—ABCB8—Transmembrane transport of small molecules—SLC9A4—celiac disease	0.00641	0.0303	CbGpPWpGaD
Doxorubicin—YWHAG—lymphoid tissue—celiac disease	0.0063	0.00798	CbGeAlD
Doxorubicin—ABCC6—blood—celiac disease	0.00629	0.00798	CbGeAlD
Doxorubicin—YWHAG—digestive system—celiac disease	0.00622	0.00788	CbGeAlD
Doxorubicin—XDH—digestive system—celiac disease	0.00606	0.00769	CbGeAlD
Doxorubicin—AKR1C3—pancreas—celiac disease	0.00606	0.00769	CbGeAlD
Doxorubicin—AURKA—liver—celiac disease	0.00604	0.00765	CbGeAlD
Doxorubicin—YWHAG—blood—celiac disease	0.00592	0.00751	CbGeAlD
Doxorubicin—ABCB11—digestive system—celiac disease	0.00592	0.00751	CbGeAlD
Doxorubicin—NQO1—connective tissue—celiac disease	0.00582	0.00737	CbGeAlD
Doxorubicin—NQO1—Aryl Hydrocarbon Receptor Pathway—IL12A—celiac disease	0.00563	0.0266	CbGpPWpGaD
Doxorubicin—RALBP1—digestive system—celiac disease	0.00562	0.00712	CbGeAlD
Doxorubicin—NOS3—lymphoid tissue—celiac disease	0.00559	0.00709	CbGeAlD
Doxorubicin—NOS3—digestive system—celiac disease	0.00552	0.007	CbGeAlD
Doxorubicin—NQO1—epithelium—celiac disease	0.00552	0.007	CbGeAlD
Doxorubicin—NDUFS2—liver—celiac disease	0.00538	0.00682	CbGeAlD
Doxorubicin—RALBP1—blood—celiac disease	0.00535	0.00678	CbGeAlD
Doxorubicin—NQO1—smooth muscle tissue—celiac disease	0.00532	0.00674	CbGeAlD
Doxorubicin—NDUFS3—liver—celiac disease	0.00531	0.00674	CbGeAlD
Doxorubicin—CBR1—lymphoid tissue—celiac disease	0.00531	0.00673	CbGeAlD
Doxorubicin—NOS3—blood—celiac disease	0.00526	0.00667	CbGeAlD
Doxorubicin—CBR1—digestive system—celiac disease	0.00524	0.00665	CbGeAlD
Doxorubicin—DHCR7—liver—celiac disease	0.00505	0.0064	CbGeAlD
Doxorubicin—CBR1—blood—celiac disease	0.00499	0.00633	CbGeAlD
Doxorubicin—AKR1C3—blood—celiac disease	0.00493	0.00625	CbGeAlD
Doxorubicin—ABCC6—liver—celiac disease	0.00492	0.00624	CbGeAlD
Doxorubicin—NQO1—pancreas—celiac disease	0.00492	0.00624	CbGeAlD
Doxorubicin—NOS2—IL12-mediated signaling events—IL12A—celiac disease	0.00478	0.0226	CbGpPWpGaD
Doxorubicin—NOS2—IL23-mediated signaling events—IL17A—celiac disease	0.00475	0.0225	CbGpPWpGaD
Doxorubicin—YWHAG—liver—celiac disease	0.00463	0.00587	CbGeAlD
Doxorubicin—NOS3—Thromboxane A2 receptor signaling—TGM2—celiac disease	0.00452	0.0214	CbGpPWpGaD
Doxorubicin—XDH—liver—celiac disease	0.00452	0.00573	CbGeAlD
Doxorubicin—POR—blood—celiac disease	0.0045	0.00571	CbGeAlD
Doxorubicin—ABCB11—liver—celiac disease	0.00441	0.0056	CbGeAlD
Doxorubicin—NQO1—digestive system—celiac disease	0.0042	0.00533	CbGeAlD
Doxorubicin—TOP2A—blood—celiac disease	0.0042	0.00532	CbGeAlD
Doxorubicin—RALBP1—liver—celiac disease	0.00418	0.0053	CbGeAlD
Doxorubicin—NOS3—liver—celiac disease	0.00412	0.00522	CbGeAlD
Doxorubicin—CYP1B1—connective tissue—celiac disease	0.00408	0.00518	CbGeAlD
Doxorubicin—SLC22A16—Transmembrane transport of small molecules—SLC9A4—celiac disease	0.00396	0.0187	CbGpPWpGaD
Doxorubicin—CBR1—liver—celiac disease	0.00391	0.00495	CbGeAlD
Doxorubicin—AKR1C3—liver—celiac disease	0.00386	0.00489	CbGeAlD
Doxorubicin—ABCC10—lymphoid tissue—celiac disease	0.0038	0.00481	CbGeAlD
Doxorubicin—ABCC3—digestive system—celiac disease	0.00377	0.00478	CbGeAlD
Doxorubicin—ABCC10—digestive system—celiac disease	0.00375	0.00476	CbGeAlD
Doxorubicin—CYP1B1—smooth muscle tissue—celiac disease	0.00374	0.00474	CbGeAlD
Doxorubicin—NQO1—Apoptosis-related network due to altered Notch3 in ovarian cancer—ETS1—celiac disease	0.00371	0.0176	CbGpPWpGaD
Doxorubicin—AURKA—Integrated Breast Cancer Pathway—ZMIZ1—celiac disease	0.00361	0.0171	CbGpPWpGaD
Doxorubicin—ABCC3—blood—celiac disease	0.00359	0.00455	CbGeAlD
Doxorubicin—ABCC10—blood—celiac disease	0.00357	0.00453	CbGeAlD
Doxorubicin—POR—liver—celiac disease	0.00352	0.00447	CbGeAlD
Doxorubicin—NOS1—Myometrial Relaxation and Contraction Pathways—RGS1—celiac disease	0.00342	0.0162	CbGpPWpGaD
Doxorubicin—NOS2—HIF-1-alpha transcription factor network—ETS1—celiac disease	0.00327	0.0155	CbGpPWpGaD
Doxorubicin—NOS3—Angiopoietin receptor Tie2-mediated signaling—ETS1—celiac disease	0.00317	0.015	CbGpPWpGaD
Doxorubicin—NQO1—liver—celiac disease	0.00313	0.00397	CbGeAlD
Doxorubicin—ABCC2—digestive system—celiac disease	0.00301	0.00382	CbGeAlD
Doxorubicin—ABCC6—Transmembrane transport of small molecules—SLC9A4—celiac disease	0.003	0.0142	CbGpPWpGaD
Doxorubicin—CYP1B1—lymphoid tissue—celiac disease	0.00299	0.00379	CbGeAlD
Doxorubicin—CYP1B1—digestive system—celiac disease	0.00295	0.00374	CbGeAlD
Doxorubicin—ABCC2—blood—celiac disease	0.00287	0.00364	CbGeAlD
Doxorubicin—CYP1B1—blood—celiac disease	0.00281	0.00356	CbGeAlD
Doxorubicin—ABCC3—liver—celiac disease	0.00281	0.00356	CbGeAlD
Doxorubicin—ABCC10—liver—celiac disease	0.00279	0.00354	CbGeAlD
Doxorubicin—NOS1—Spinal Cord Injury—FCGR2A—celiac disease	0.00274	0.013	CbGpPWpGaD
Doxorubicin—CYP1B1—Aryl Hydrocarbon Receptor Pathway—IL12A—celiac disease	0.0027	0.0128	CbGpPWpGaD
Doxorubicin—ABCC10—Transmembrane transport of small molecules—SLC9A4—celiac disease	0.00262	0.0124	CbGpPWpGaD
Doxorubicin—YWHAG—Calcium Regulation in the Cardiac Cell—RGS1—celiac disease	0.0026	0.0123	CbGpPWpGaD
Doxorubicin—ABCC1—blood—celiac disease	0.00253	0.0032	CbGeAlD
Doxorubicin—YWHAG—Myometrial Relaxation and Contraction Pathways—RGS1—celiac disease	0.00252	0.0119	CbGpPWpGaD
Doxorubicin—NOS3—Signaling events mediated by VEGFR1 and VEGFR2—PTPN2—celiac disease	0.00239	0.0113	CbGpPWpGaD
Doxorubicin—ABCG2—HIF-2-alpha transcription factor network—ETS1—celiac disease	0.00231	0.011	CbGpPWpGaD
Doxorubicin—ABCC2—liver—celiac disease	0.00224	0.00285	CbGeAlD
Doxorubicin—CYP1B1—liver—celiac disease	0.0022	0.00279	CbGeAlD
Doxorubicin—NOS2—IL12-mediated signaling events—CD8A—celiac disease	0.00217	0.0103	CbGpPWpGaD
Doxorubicin—ABCB1—Allograft Rejection—IL21—celiac disease	0.00217	0.0103	CbGpPWpGaD
Doxorubicin—ABCB1—Allograft Rejection—MICA—celiac disease	0.00217	0.0103	CbGpPWpGaD
Doxorubicin—ABCG2—blood—celiac disease	0.00209	0.00265	CbGeAlD
Doxorubicin—NOS2—Spinal Cord Injury—FCGR2A—celiac disease	0.00207	0.00978	CbGpPWpGaD
Doxorubicin—CYP2B6—lymphoid tissue—celiac disease	0.00205	0.0026	CbGeAlD
Doxorubicin—CYP2B6—digestive system—celiac disease	0.00203	0.00257	CbGeAlD
Doxorubicin—YWHAG—SIDS Susceptibility Pathways—RUNX3—celiac disease	0.00202	0.00957	CbGpPWpGaD
Doxorubicin—NOS3—Myometrial Relaxation and Contraction Pathways—RGS1—celiac disease	0.002	0.00948	CbGpPWpGaD
Doxorubicin—ABCC1—liver—celiac disease	0.00198	0.00251	CbGeAlD
Doxorubicin—CYP2B6—blood—celiac disease	0.00193	0.00245	CbGeAlD
Doxorubicin—YWHAG—PDGFR-beta signaling pathway—PTPN2—celiac disease	0.00185	0.00875	CbGpPWpGaD
Doxorubicin—NOS2—IL23-mediated signaling events—CD4—celiac disease	0.00183	0.00868	CbGpPWpGaD
Doxorubicin—NOS2—IL12-mediated signaling events—HLA-DRB1—celiac disease	0.00177	0.00836	CbGpPWpGaD
Doxorubicin—NDUFS3—Metabolism—LCT—celiac disease	0.00172	0.00816	CbGpPWpGaD
Doxorubicin—NDUFS7—Metabolism—LCT—celiac disease	0.00172	0.00816	CbGpPWpGaD
Doxorubicin—ABCG2—liver—celiac disease	0.00164	0.00207	CbGeAlD
Doxorubicin—NDUFS2—Metabolism—LCT—celiac disease	0.00162	0.00767	CbGpPWpGaD
Doxorubicin—CYP3A4—digestive system—celiac disease	0.00153	0.00194	CbGeAlD
Doxorubicin—CYP2B6—liver—celiac disease	0.00151	0.00191	CbGeAlD
Doxorubicin—CYP2D6—digestive system—celiac disease	0.00151	0.00191	CbGeAlD
Doxorubicin—CYP3A4—blood—celiac disease	0.00146	0.00185	CbGeAlD
Doxorubicin—RALBP1—Signaling Pathways—ARHGAP31—celiac disease	0.00144	0.00682	CbGpPWpGaD
Doxorubicin—CYP2D6—blood—celiac disease	0.00143	0.00182	CbGeAlD
Doxorubicin—ABCB1—epithelium—celiac disease	0.00142	0.00181	CbGeAlD
Doxorubicin—DHCR7—Metabolism—LCT—celiac disease	0.00138	0.00652	CbGpPWpGaD
Doxorubicin—ABCG2—HIF-1-alpha transcription factor network—ETS1—celiac disease	0.00136	0.00644	CbGpPWpGaD
Doxorubicin—NOS1—Hemostasis—PLEK—celiac disease	0.00135	0.0064	CbGpPWpGaD
Doxorubicin—CBR1—Metabolism—LCT—celiac disease	0.00128	0.00608	CbGpPWpGaD
Doxorubicin—ABCB1—pancreas—celiac disease	0.00127	0.00161	CbGeAlD
Doxorubicin—NOS1—Disease—LCT—celiac disease	0.00125	0.0059	CbGpPWpGaD
Doxorubicin—NOS2—IL12-mediated signaling events—CD4—celiac disease	0.00125	0.0059	CbGpPWpGaD
Doxorubicin—CYP3A4—liver—celiac disease	0.00114	0.00145	CbGeAlD
Doxorubicin—CYP2D6—liver—celiac disease	0.00112	0.00142	CbGeAlD
Doxorubicin—ABCB1—lymphoid tissue—celiac disease	0.0011	0.00139	CbGeAlD
Doxorubicin—ABCB1—digestive system—celiac disease	0.00108	0.00137	CbGeAlD
Doxorubicin—ABCB1—blood—celiac disease	0.00103	0.00131	CbGeAlD
Doxorubicin—NOS2—Hemostasis—PLEK—celiac disease	0.00102	0.00483	CbGpPWpGaD
Doxorubicin—ABCC3—Transmembrane transport of small molecules—SLC9A4—celiac disease	0.00102	0.00481	CbGpPWpGaD
Doxorubicin—YWHAG—SIDS Susceptibility Pathways—IL10—celiac disease	0.000998	0.00472	CbGpPWpGaD
Doxorubicin—NOS2—Disease—LCT—celiac disease	0.00094	0.00445	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—MYO9B—celiac disease	0.000873	0.00413	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—LCT—celiac disease	0.000864	0.00409	CbGpPWpGaD
Doxorubicin—ABCB1—Allograft Rejection—IL12A—celiac disease	0.000863	0.00408	CbGpPWpGaD
Doxorubicin—NOS1—Hemostasis—SH2B3—celiac disease	0.000849	0.00402	CbGpPWpGaD
Doxorubicin—ABCB1—liver—celiac disease	0.000807	0.00102	CbGeAlD
Doxorubicin—ABCC2—Transmembrane transport of small molecules—SLC9A4—celiac disease	0.000805	0.00381	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—ARHGAP31—celiac disease	0.000798	0.00378	CbGpPWpGaD
Doxorubicin—ABCC1—Transmembrane transport of small molecules—SLC9A4—celiac disease	0.000795	0.00377	CbGpPWpGaD
Doxorubicin—NOS3—Hemostasis—PLEK—celiac disease	0.000792	0.00375	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—TAGAP—celiac disease	0.000757	0.00358	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—LCT—celiac disease	0.00075	0.00355	CbGpPWpGaD
Doxorubicin—ABCB1—HIF-1-alpha transcription factor network—ETS1—celiac disease	0.000736	0.00348	CbGpPWpGaD
Doxorubicin—NOS3—Disease—LCT—celiac disease	0.00073	0.00346	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—LCT—celiac disease	0.000724	0.00343	CbGpPWpGaD
Doxorubicin—ABCG2—Transmembrane transport of small molecules—SLC9A4—celiac disease	0.0007	0.00331	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—ARHGAP31—celiac disease	0.000675	0.00319	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—LCT—celiac disease	0.000673	0.00318	CbGpPWpGaD
Doxorubicin—NOS2—Hemostasis—SH2B3—celiac disease	0.000641	0.00303	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—LCT—celiac disease	0.000611	0.00289	CbGpPWpGaD
Doxorubicin—ABCB1—Allograft Rejection—IL17A—celiac disease	0.000583	0.00276	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—RGS1—celiac disease	0.000563	0.00266	CbGpPWpGaD
Doxorubicin—ABCB1—Allograft Rejection—HLA-DPB1—celiac disease	0.000537	0.00254	CbGpPWpGaD
Doxorubicin—ABCB1—Allograft Rejection—CTLA4—celiac disease	0.000509	0.00241	CbGpPWpGaD
Doxorubicin—NOS3—Hemostasis—SH2B3—celiac disease	0.000497	0.00235	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—LCT—celiac disease	0.000496	0.00235	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—MYO9B—celiac disease	0.000484	0.00229	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—LCT—celiac disease	0.000475	0.00225	CbGpPWpGaD
Doxorubicin—ABCB1—Allograft Rejection—HLA-DQA1—celiac disease	0.000448	0.00212	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—LCT—celiac disease	0.000445	0.00211	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—CCR4—celiac disease	0.000435	0.00206	CbGpPWpGaD
Doxorubicin—ABCB1—Allograft Rejection—HLA-DQB1—celiac disease	0.000419	0.00199	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—TAGAP—celiac disease	0.000419	0.00199	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—MYO9B—celiac disease	0.000409	0.00193	CbGpPWpGaD
Doxorubicin—ABCB1—Allograft Rejection—IL10—celiac disease	0.000396	0.00188	CbGpPWpGaD
Doxorubicin—ABCB1—Transmembrane transport of small molecules—SLC9A4—celiac disease	0.000378	0.00179	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—LCT—celiac disease	0.000373	0.00176	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—CCR3—celiac disease	0.00037	0.00175	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—LCT—celiac disease	0.00036	0.00171	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—SH2B3—celiac disease	0.00036	0.00171	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—TAGAP—celiac disease	0.000354	0.00168	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—LCT—celiac disease	0.000328	0.00155	CbGpPWpGaD
Doxorubicin—ABCB1—Allograft Rejection—HLA-DRB1—celiac disease	0.000319	0.00151	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—RGS1—celiac disease	0.000312	0.00148	CbGpPWpGaD
Doxorubicin—ABCB1—Allograft Rejection—CD80—celiac disease	0.000295	0.00139	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—RGS1—celiac disease	0.000263	0.00125	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—CCR4—celiac disease	0.000241	0.00114	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—LCT—celiac disease	0.00024	0.00114	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—CCR3—celiac disease	0.000205	0.00097	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—CCR4—celiac disease	0.000204	0.000964	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—SH2B3—celiac disease	0.0002	0.000945	CbGpPWpGaD
Doxorubicin—NOS1—Disease—CD80—celiac disease	0.00019	0.0009	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—LCT—celiac disease	0.000177	0.000839	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—CCR3—celiac disease	0.000173	0.000819	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—SH2B3—celiac disease	0.000169	0.000798	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—LCT—celiac disease	0.000167	0.000791	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—CD80—celiac disease	0.000167	0.000789	CbGpPWpGaD
Doxorubicin—NOS1—Disease—CD4—celiac disease	0.000145	0.000687	CbGpPWpGaD
Doxorubicin—NOS2—Disease—CD80—celiac disease	0.000143	0.000679	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—CD80—celiac disease	0.000132	0.000624	CbGpPWpGaD
Doxorubicin—NOS3—Disease—CD80—celiac disease	0.000111	0.000527	CbGpPWpGaD
Doxorubicin—NOS2—Disease—CD4—celiac disease	0.00011	0.000518	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—LCT—celiac disease	0.000109	0.000517	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—CD4—celiac disease	0.000101	0.000476	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—CD80—celiac disease	9.23e-05	0.000437	CbGpPWpGaD
Doxorubicin—NOS3—Disease—CD4—celiac disease	8.5e-05	0.000403	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—CD80—celiac disease	7.8e-05	0.000369	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—CD80—celiac disease	6.79e-05	0.000321	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—CD4—celiac disease	5.18e-05	0.000245	CbGpPWpGaD
